Works matching IS 00099236 AND DT 2023 AND VI 114 AND IP 2
Results: 26
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7‐Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit‐Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 470, doi. 10.1002/cpt.2968
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 247, doi. 10.1002/cpt.2967
- Publication type:
- Article
Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 459, doi. 10.1002/cpt.2965
- By:
- Publication type:
- Article
Understanding the Mechanism and Extent of Transplacental Transfer of (−)‐∆<sup>9</sup>‐Tetrahydrocannabinol (THC) in the Perfused Human Placenta to Predict In Vivo Fetal THC Exposure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 446, doi. 10.1002/cpt.2964
- By:
- Publication type:
- Article
External Control Arms: We're Not on Cruise Control Yet.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 249, doi. 10.1002/cpt.2963
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 254, doi. 10.1002/cpt.2962
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 252, doi. 10.1002/cpt.2961
- Publication type:
- Article
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 434, doi. 10.1002/cpt.2959
- By:
- Publication type:
- Article
Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 423, doi. 10.1002/cpt.2958
- By:
- Publication type:
- Article
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 275, doi. 10.1002/cpt.2957
- By:
- Publication type:
- Article
Response‐Based Dosing for Ponatinib: Model‐Based Analyses of the Dose‐Ranging OPTIC Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 413, doi. 10.1002/cpt.2956
- By:
- Publication type:
- Article
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 356, doi. 10.1002/cpt.2936
- By:
- Publication type:
- Article
Reply to "Questioning Bayesian Inference‐Based Models for Estimating Culprit Drugs for Adverse Drug Reactions".
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 260, doi. 10.1002/cpt.2935
- By:
- Publication type:
- Article
Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 393, doi. 10.1002/cpt.2934
- By:
- Publication type:
- Article
Questioning Bayesian Inference‐Based Models for Estimating Culprit Drugs for Adverse Drug Reactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 259, doi. 10.1002/cpt.2933
- By:
- Publication type:
- Article
Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 303, doi. 10.1002/cpt.2913
- By:
- Publication type:
- Article
Drug‐Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 404, doi. 10.1002/cpt.2930
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 371, doi. 10.1002/cpt.2929
- By:
- Publication type:
- Article
Biomarker‐Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 316, doi. 10.1002/cpt.2928
- By:
- Publication type:
- Article
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 325, doi. 10.1002/cpt.2914
- By:
- Publication type:
- Article
The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 381, doi. 10.1002/cpt.2932
- By:
- Publication type:
- Article
Exploratory Food Effect Assessment in Patients in Early Clinical Development of Oncology Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 288, doi. 10.1002/cpt.2911
- By:
- Publication type:
- Article
Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 262, doi. 10.1002/cpt.2910
- By:
- Publication type:
- Article
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 362, doi. 10.1002/cpt.2902
- By:
- Publication type:
- Article
Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 266, doi. 10.1002/cpt.2873
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 239, doi. 10.1002/cpt.2660
- Publication type:
- Article